"A lot will also depend on price... outside the US
Post# of 148181
(Total Views: 722)
Posted On: 11/09/2020 11:34:02 AM
"A lot will also depend on price... outside the US, prophylaxis may be too costly/it may make more sense to treat only those 15% that progress to Severe/Critical."
I'm confused. Are you referring to Leronlimab here or to the Pfizer vaccine to treat Severe/Critical. I have limited medical knowledge but thought that a vaccine would not be helpful for patients already sick with Covid since their immune systems will already have been stimulated plenty enough to produce antibodies. Please clarify.
I'm confused. Are you referring to Leronlimab here or to the Pfizer vaccine to treat Severe/Critical. I have limited medical knowledge but thought that a vaccine would not be helpful for patients already sick with Covid since their immune systems will already have been stimulated plenty enough to produce antibodies. Please clarify.
(0)
(0)CytoDyn Inc (CYDY) Stock Research Links
Scroll down for more posts ▼